Today: 20 May 2026
Tesla stock heads into a big week: $99 FSD push, robotaxi talk and earnings on deck

Tesla stock heads into a big week: $99 FSD push, robotaxi talk and earnings on deck

New York, Jan 24, 2026, 09:58 EST — The market has closed.

  • Tesla shares closed Friday marginally lower, slipping 0.07% to $449.06.
  • Tesla is nudging new buyers in North America toward its $99-per-month Full Self-Driving subscription by removing certain bundled driver-assist features.
  • CEO Elon Musk said he expects regulatory approval for Tesla’s driver-supervised FSD system in Europe as soon as next month, with China following a similar schedule.

Tesla shares ended Friday mostly flat, setting the stage for a headline-packed weekend ahead of the company’s quarterly earnings next week.

Why it matters now: Tesla is doubling down on software and autonomy-related income just as investors seek evidence the company can boost margins without relying on a new surge in car sales.

Timing is another factor. Tesla’s update on Jan. 28 comes during a packed week for major tech earnings and heightened macro risks, which can cause sharp moves in high-valuation stocks.

On Thursday, Tesla removed certain driver-assistance features from new vehicles sold in the U.S. and Canada. Buyers seeking self-steering will now need to subscribe to the $99-per-month Full Self-Driving (Supervised) package.

FSD (Supervised) is Tesla’s term for an advanced driver-assistance system: it can steer and manage certain driving tasks, but the driver must stay alert and the system keeps tabs on them. Autosteer — which helps keep the vehicle centered in its lane on highways — is no longer standard, though Traffic Aware Cruise Control still comes included.

Musk informed customers that the subscription price will increase as features get better, sparking complaints from some owners on social media, Reuters reported.

In Davos, Musk expressed optimism that Tesla might secure regulatory approval in Europe “hopefully next month,” adding that China could see a similar timeline. According to Reuters, a Dutch vehicle authority expects to make a decision on FSD by February. Reuters

According to the same Reuters report, Tesla has kicked off robotaxi rides in Austin, Texas, operating without safety monitors onboard. Shares surged 4.2% on Thursday following social media buzz about the driverless trips, but ended flat on Friday.

The shift toward autonomy also brings significant risks. Regulators have been keeping a close eye on driver-assistance systems, and any delays in approvals—or fresh restrictions following incidents—could slow Tesla’s efforts to ramp up software sales. On top of that, consumer backlash remains a wildcard if key features start disappearing behind a paywall.

Ken Mahoney of Mahoney Asset Management, a Tesla shareholder, emphasized that investors want “credible evidence” on the manufacturing scale and regulatory approval path for Tesla’s Optimus robot plans. His comments highlight how investor focus can pivot swiftly from cars to futuristic promises. Reuters

Tesla is set to release its fourth-quarter results on Jan. 28, followed by a Q&A session. Investors will be digging for news on FSD adoption, changes to North America features, and any new timelines for growth in Europe and China.

Stock Market Today

  • Parabilis Plans IPO to Fund Phase 3 Trial for Tumor Drug Following Regeneron Deal
    May 20, 2026, 5:56 AM EDT. Parabilis Medicines, a Massachusetts biotech, is preparing for an initial public offering (IPO) to finance the phase 3 trial of its tumor drug zolucatetide, targeting rare desmoid tumors. The drug, which inhibits the Wnt/β-catenin pathway implicated in many cancers, recently received FDA fast-track status. Proceeds will also support phase 1 trials for additional cancers. Parabilis secured a $50 million upfront payment and a $75 million equity investment from Regeneron in a deal to explore Parabilis' helicon peptide platform. The firm boasts over $300 million in cash from prior funding rounds. CEO Mathai Mammen aims to grow Parabilis into a fully integrated research, development, manufacturing, and commercialization company, relying on partnerships to finance its ambitions.

Latest articles

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

20 May 2026
OCI Energy and CPS Energy have begun building a 120-megawatt battery storage facility in southeastern Bexar County, aiming for commercial operation in 2027. The project follows a rise in average outage duration for CPS Energy customers to 75.38 minutes in 2025. OCI will own the facility, with CPS holding operational control. ING is financing construction, and LG Energy Solution Vertech is supplying batteries.
Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics Jumps; $3 Million Deal Looms

20 May 2026
Co-Diagnostics announced a $3 million private placement after its stock surged 43.8% Tuesday, then fell 13.3% in after-hours trading. The company will sell 1.65 million shares or pre-funded warrants, plus warrants for up to 3.29 million more shares, nearly doubling its share count. The move follows its completion of a Bundibugyo virus assay as Ebola spreads in Congo and Uganda. Co-Diagnostics reported $8.2 million in cash at March 31.
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
Disney stock slips into weekend as board flags CEO pick “early 2026” and earnings loom
Previous Story

Disney stock slips into weekend as board flags CEO pick “early 2026” and earnings loom

Exxon stock price: XTO’s Eagle Ford sale push puts XOM in play ahead of key week
Next Story

Exxon stock price: XTO’s Eagle Ford sale push puts XOM in play ahead of key week

Go toTop